LD-2 disclosure · 2nd Quarter - Amendment
1DAY SOONER ACTION PROJECT
Client
- Description
- advocacy organization supporting medical research
- Location
- Delaware · United States of America
Registrant
- Location
- Fairfax, Virginia, United States of America
Lobbying activities
3 issuesHealth Issues
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Lobbyistsms JENNY CAROLINE DEBERRY
Covered position (ms JENNY CAROLINE DEBERRY): Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS)
Medical/Disease Research/Clinical Labs
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives